TLR5 and neoplasm: To validate the imaging results and further quantify 125I-antiTLR5 mAb uptake at 24, 48, and 72 h, biodistribution studies in vitro proceeded 14 days after TLR5+ 4T1 and TLR5− 4T1 tumor cell inoculation.